$37.400
-1.201 (-3.21%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
OR Prediction & Forecast by Similar Chart Analysis
Alphio's OR stock price prediction model matches the current OR Royalties Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $37.01 (-1.05%). The 1-week path is $36.16 (-3.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy OR Royalties Inc Stock?
Osisko Gold Royalties Ltd is a good buy right now due to its strong financial performance, evidenced by a Q2 revenue of $97.82 million, which is a 62.0% year-over-year increase, and a gross margin of 86.39% in Q1 2026. Additionally, the stock has shown positive momentum with a 25.67% increase over the last 20 days and a current RSI of 61.62, indicating bullish sentiment. However, the main risk is the forward P/E ratio of 30.49, which suggests that the stock may be overvalued if earnings do not meet expectations in the coming quarters.
OR stock price ended at $37.40 on Friday, after losing -3.21%
OR Royalties Inc (OR) last closed at $37.4, losing -3.21%. These facts feed the 1-day and 1-week OR price prediction above.
Forecast Drivers
OR Royalties Inc (OR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches OR, ranked by similarity.
Seasonality analysis for OR
Historically the probability of a positive August return for OR is 79.37%. April offers the highest probability of a positive month at 100.00%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.